February 08, 2020   Glaucoma 360: Day 2   Glaucoma 360: Fostering innovation in the face of costs, policy issues Delivering the opening keynote address, David W. Parke II, MD, CEO of the American Academy of Ophthalmology, points out that patients and physicians can benefit from innovations in treatment. However, health policy and economics often can stand in the way of innovation. Read on Contact lens drug delivery for glaucoma: A better way to get there Diopter Corp./Glint Pharmaceuticals CEO Chris Adams discusses a contact lens device that has been found effective for treating glaucoma because it was engineered with vitamin E nano-barriers to extend drug release. Learn more Glaucoma 360 shines spotlight on innovation Adrienne Graves, PhD, and Andrew Iwach, MD, Glaucoma 360 co-founders and co-chairs, discuss a few of the highlights for this year’s meeting. Watch the video RELATED ARTICLES   Glaucoma 360 Symposia: The eye on education All eyes on innovation at Glaucoma 360 New Horizons Forum Glaucoma 360 kicks off with Gala Episode 10: Glaucoma 360: What’s new for 2020